Oramed Pharmaceuticals
ORMP
#9143
Rank
โ‚น18.62 B
Marketcap
โ‚น447.85
Share price
0.21%
Change (1 day)
119.06%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2026 (TTM): โ‚น6.94 Billion

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of โ‚น7.46 Billion, an increase over its 2024 earnings that were of -โ‚น1.45 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น6.94 B-7.02%
2025 โ‚น7.46 B-616.9%
2024 -โ‚น1.45 Billion-311.47%
2023 โ‚น0.68 B-119.45%
2022 -โ‚น3.52 Billion39.17%
2021 -โ‚น2.53 Billion73.93%
2020 -โ‚น1.46 Billion18.53%
2019 -โ‚น1.23 Billion-16.62%
2018 -โ‚น1.47 Billion38.32%
2017 -โ‚น1.07 Billion12.51%
2016 -โ‚น0.95 Billion25.01%
2015 -โ‚น0.76 Billion18.18%
2014 -โ‚น0.64 Billion39.72%
2013 -โ‚น0.46 Billion46.4%
2012 -โ‚น0.32 Billion128.32%
2011 -โ‚น0.14 Billion-51.47%
2010 -โ‚น0.29 Billion35.21%
2009 -โ‚น0.21 Billion
2007 -โ‚น0.33 Billion607.04%
2006 -โ‚น46.35 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novo Nordisk
NVO
โ‚น2.398 T 31,672.04%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
โ‚น734.44 B 9,628.39%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-โ‚น51.46 Billion-781.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-โ‚น2.51 Billion-133.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
โ‚น3.34 B-55.69%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel